Anne-Marie Duliege, EVP & Chief Medical Officer at RIGEL PHARMACEUTICALS INC (RIGL), sold 5,000 shares at $2.79 ($14K) on 2018-07-02, disclosed to the SEC on 2018-07-05.
Scheduled sale ($14k) by EVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RIGL | SELL | 2018-04-24 | $21K | — | Filing → |
| RIGL | SELL | 2017-07-07 | $13K | — | Filing → |
| RIGL | SELL | 2017-01-13 | $12K | — | Filing → |